3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malnutrition
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Colorectal Neoplasms
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcopenia
1
Polycystic Ovary Syndrome
1
Perioperative Complication
1
Obesity
1
Nutrition Disorders
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Food Preferences
1
Esophageal Neoplasms
1
Duodenal Neoplasms
1
Diabetes, Gestational
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Body Weight Changes
1
Anosmia
1
Interventions
Oxaliplatin
290
Capecitabine
206
Fluorouracil
181
Cisplatin
168
Docetaxel
138
S 1 (combination)
132
Paclitaxel
121
Leucovorin
116
Irinotecan
106
pembrolizumab
103
Trastuzumab
72
apatinib
56
Nivolumab
56
sintilimab
45
Drug Therapy
43
Surgical Procedures, Operative
37
Radiotherapy
37
Bevacizumab
37
Ramucirumab
34
titanium silicide
31
Hyperthermic Intraperitoneal Chemotherapy
30
Epirubicin
30
Carboplatin
30
tislelizumab
28
Cyclophosphamide
27
XELOX
24
Tegafur
23
Folfox protocol
22
Albumin-Bound Paclitaxel
22
camrelizumab
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Stomach Neoplasms
×
Nutrition Therapy
×
Clear all
NCT06414122
2025-03-19
MOMENT
University of Cologne
Phase NA
Not yet recruiting
88 enrolled